MDA Supports Bill to Ease Biotech Restrictions

MDA has joined some 30 other organizations that fund medical research in urging Congress to ease restrictions on small business grants for new biotechnology companies.

Recent changes in the government’s Small Business Administration grants program have excluded companies that rely heavily on outside investors (venture capitalists), which describes most biotech startup firms. The Biotechnology Industry Organization (BIO) is sponsoring a bill (H.R. 2943 and S.1263) to lift this restriction.